AAV9 delivered bispecific nanobody attenuates amyloid burden in the gelsolin amyloidosis mouse model
File version
Author(s)
Nair, Nisha
Everaert, Inge
Van Overbeke, Wouter
Supply, Lynn
Zwaenepoel, Olivier
Peleman, Cindy
Van Dorpe, Jo
Lahoutte, Tony
Devoogdt, Nick
Derave, Wim
Chuah, Marinee K
VandenDriessche, Thierry
Gettemans, Jan
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
Size
File type(s)
Location
License
Abstract
This is a correction to: Human Molecular Genetics, Volume 26, Issue 7, 1 April 2017, Pages 1353–1364, https://doi.org/10.1093/hmg/ddx056 The Authors would like to apologize for a spelling error in the name of one of the co-authors. The correct spelling is Thierry VandenDriessche, in one word. This has now been corrected online.
Journal Title
Human Molecular Genetics
Conference Title
Book Title
Edition
Volume
26
Issue
15
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject
Biological sciences
Biomedical and clinical sciences
Science & Technology
Life Sciences & Biomedicine
Biochemistry & Molecular Biology
Genetics & Heredity
Persistent link to this record
Citation
Verhelle, A; Nair, N; Everaert, I; Van Overbeke, W; Supply, L; Zwaenepoel, O; Peleman, C; Van Dorpe, J; Lahoutte, T; Devoogdt, N; Derave, W; Chuah, MK; VandenDriessche, T; Gettemans, J, AAV9 delivered bispecific nanobody attenuates amyloid burden in the gelsolin amyloidosis mouse model, Human Molecular Genetics, 2017, 26 (15), pp. 3030-3030